Investigating Dupilumab's Effect in Asthma by Genotype Read more about Investigating Dupilumab's Effect in Asthma by Genotype
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma Read more about Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps. Read more about RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.
A Study of PRN1008 in Adult Patients With Immune Thrombocytopenia (ITP) Read more about A Study of PRN1008 in Adult Patients With Immune Thrombocytopenia (ITP)
Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery Read more about Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery
BIO 300 Oral Suspension in Discharged COVID-19 Patients Read more about BIO 300 Oral Suspension in Discharged COVID-19 Patients
A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat Read more about A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat
A Study of Acute Respiratory Infections in Global Outpatient Setting Read more about A Study of Acute Respiratory Infections in Global Outpatient Setting
A Study of Bemarituzumab Monotherapy and Docetaxel Combination in Participants With Squamous Non-small-cell Lung Cancer (SqNSCLC) With Fibroblast Growth Factor Receptor Isoform 2b (FGFR2b) Overexpression Read more about A Study of Bemarituzumab Monotherapy and Docetaxel Combination in Participants With Squamous Non-small-cell Lung Cancer (SqNSCLC) With Fibroblast Growth Factor Receptor Isoform 2b (FGFR2b) Overexpression
A Trial of TTI-622 in Patients With Advanced Hematologic Malignancies Read more about A Trial of TTI-622 in Patients With Advanced Hematologic Malignancies